baber/WOPTO huggingface dataset:
Patent CA-2860156-A1 (CA)
Inventor: KAMEN DEAN
IPC: G16H20/17
Filed: 2011-12-21
Abstract: A system for electronic patient care includes a hub. The hub is configured to monitor a patient-care device. The sandbox may be configured to control access to at least one of a hardware resource and a software resource. The hub is further configured to identify the patient-care device and execute an application to monitor the patient-care device. The hub executes the application within the sandbox component such that the application accesses the at least one of the hardware resource and the software resource through the sandbox component. The hub may be further configured to control the patient-care device. The hub may be further configured to receive an identification from the patient-care device and download the application from a server associated with the identification. The hub may be further configured to receive an identification from the patient-care device and update the application from a server associated with the identification.
Patent CA-2862472-A1 (CA)
Title: Polygonal aerosol-generating device and system
Inventor: PLOJOUX JULIEN
IPC: A24F40/90
Filed: 2012-12-28
Abstract: There is provided an elongate aerosol-generating device (100) having a polygonal transverse cross-section. The polygon comprises at least 6sides. The elongate aerosol-generating device may comprise a substrate receiving cavity (302) adapted to receive an aerosol-forming substrate, a heating element (406) adapted to heat an aerosol-forming substrate to generate an aerosol, and a power supply (506) adapted to provide power to the heating element. In addition, there is provided an aerosol-generating system, comprising an elongate aerosol-generating device according to any of the preceding claims, and a charging device (600) comprising a cavity (602) having a polygonal transverse cross-section corresponding to the polygonal transverse cross-section of said aerosol-generating device, the cavity being adapted to receive the elongate aerosol-generating device.
Patent CA-2862965-A1 (CA)
Title: Procede et appareil pour definition de couleurs nettes pour l'application de granules sur des substrats de toiture
Inventor: SVEC JAMES A
IPC: B32B37/24
Filed: 2014-09-09
Abstract: Un système de distribution de granules haute vitesse et une méthode sont divulgués en vue de distribuer des granules en motifs intermittents sur un substrat revêtu dasphalte en mouvement dans la fabrication de bardeaux de toiture. Le système comprend une trémie à granules et une roue à godets indexable de manière rotative au bas de la trémie. Une série de godets est formée sur la circonférence de la roue et les godets sont séparés par des bandes relevées. Un joint détanchéité au bas de la trémie fait étanchéité contre les bandes relevées lorsque la roue est indexée. En utilisation, les godets de la roue à godets avancent et sont remplis de granules au bas de la trémie. Chaque godet, indexé au-delà du joint détanchéité, est exposé au substrat revêtu dasphalte en mouvement dessous et ses granules tombent sur le substrat pour être intégrées dans lasphalte collant chaud.  La vitesse à laquelle la roue est indexée est coordonnée à la vitesse du substrat revêtu dasphalte de sorte que les granules et le substrat se déplacent à environ la même vitesse davancement ou à un rapport de vitesses présélectionné lorsque les granules tombent sur le substrat. Des motifs de granules bien définis sont possibles à des taux de production élevés. Une méthode de création dune définition de couleur linéaire franche entre les portions de granules à hautes vitesses de ligne est divulguée.
Patent CA-2865928-A1 (CA)
Inventor: SMITH ERNEST S
IPC: C07K16/24
Filed: 2013-03-01
Abstract: Methods for treating diseases associated with CXCL13 expression, including certain autoimmune and inflammatory diseases such as Sjogren's syndrome are provided herein. The methods comprise administering to a subject in need thereof an effective amount of an agent that inhibits CXCL13 activity. According to aspects of the invention illustrated herein, there is provided a method of treating, preventing, or reducing the exacerbation of a B-cell-mediated inflammatory condition in a subject, including administering to a subject an effective amount of an isolated binding molecule which specifically binds to CXCL13, wherein said molecule prevents or inhibits CXCL13 activity.
Patent CA-2866244-A1 (CA)
Inventor: JARVINEN MARKKU
IPC: E02B15/04
Filed: 2013-03-02
Abstract: Method and apparatus for extracting oil or bitumen from the soil comprising oil or bitumen or from the solid soil materials comprising oil or bitumen, such as oil sand or from ice, wherein oil or bitumen is extracted by using hot liquid so that the soil or soil material is brought in touch with hot liquid. The heat of the hot liquid extracts oil or bitumen from the soil or from the solid soil materials. Hot oil or hot water is pumped down into the soil or solid soil particles are dropped into hot oil or hot water.
Patent CA-2868470-A1 (CA)
Title: Sensing device and method of attaching the same by a cured bonding rivet
Inventor: KROHN MATTHEW HARVEY
IPC: G01N29/22
Filed: 2013-03-14
Abstract: A sensing device and a method of attaching the sensing device to a target object is disclosed. The substrate of the sensing device has one or more bonding material vias that allows the bonding material used to attach the substrate to the target object to flow from one side of the substrate to the other side of the substrate. The bonding material forms rivets to secure the substrate to the target object and to secure the layers of the substrate to each other.
Patent CA-2869367-A1 (CA)
Title: An anti-microbial dressing, an anti-microbial composition and use thereof
Inventor: PECORARI GIANNI
IPC: A61L26/00
Filed: 2013-04-04
Abstract: The invention relates to an antimicrobial dressing, an anti-microbial composition and use thereof. The dressing comprises: chlorhexidine and/or a pharmaceutically acceptable salt thereof in a solid state in a quantity, calculated as an equivalent weight of chlorhexidine digluconate/surface of dressing, comprised between 0.013 and 2 g/m2; and silver and/or a pharmaceuctically-acceptable salt in the solid state in a quantity, calculated as an equivalent weight of metallic silver/surface of dressing of greater than or equal to 0.1 g/m2. The composition comprises: chlorhexidine and/or a pharmaceutically acceptable salt thereof in a solid state in a relative weight/weight percentage, calculated as an equivalent weight of chlorhexidine digluconate/total weight of the composition, comprised between 0.01% and 0.09%; and silver and/or a pharmaceutically acceptable salt thereof in the solid state in a relative percentage weight/weight comprised between 0.00008% and 0.08%, calculated as an equivalent weight of metallic silver/total weight of the composition; and at least a pharmaceutically- acceptable excipient.
Patent CA-2870303-A1 (CA)
Title: Organic compounds
Inventor: MATES SHARON
IPC: A61K31/4985
Filed: 2013-04-14
Abstract: The invention relates to particular substituted heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving 5-HT2A receptor, serotonin transporter (SERT) and/or pathways involving dopamine D2 receptor signaling systems..
Patent CA-2870483-A1 (CA)
Title: Appareil de reseautage et procede de reseautage
Inventor: HURD MATTHEW
IPC: H04L29/00
Filed: 2013-04-18
Abstract: La présente invention concerne un appareil de réseautage agnostique aux protocoles et un procédé de réseautage. L'appareil de réseautage reçoit un signal de couche physique par le biais d'une pluralité de ports de communication qui s'interfacent avec des systèmes informatiques externes. Un module de routage dynamique interconnecte les ports de communication avec des conduits de données discrets reconfigurables. Chacun des conduits de données définit une voie de transmission entre des ports de communication prédéterminés. Un module de gestion maintient les conduits de données sur la base de commandes de routage reçues d'un système informatique externe. Le module de gestion s'interface avec le module de routage dynamique pour mettre en place et/ou briser des conduits de données en réponse aux commandes de routage reçues.
Patent CA-2870566-A1 (CA)
Title: Thiazolecarboxamide derivatives for use as nampt inhibitors
Inventor: SWEIS RAMZI F
IPC: A61K31/427
Filed: 2013-05-10
Abstract: Disclosed are compounds which inhibit the activity of NAMPT, compositions containing the compounds and methods of treating diseases during which NAMPT is expressed.
Patent CA-2874943-A1 (CA)
Inventor: ANFRIANI ALEXANDRE
IPC: G06Q50/30
Filed: 2013-06-07
Abstract: The invention concerns a method and system for forecasting maintenance operations to be applied to an engine or to a portion of the engine comprising a set of components, the system comprising: - processing means for constructing a service life model (Bl) for each component of said set of components, - processing means for analysing the service life model associated with each component in order to construct a set of failure models (B2) corresponding to said set of components, each component being associated with a failure model defining an period between inspections that represents a heightened degradation risk level lower than a predefined safety threshold, - processing means for defining a maintenance strategy (B3) comprising selectively timed inspections of said set of components, and - processing means for iteratively simulating maintenance actions on said set of components by using said set of failure models (B2) and said maintenance strategy (B3) in order to construct an overall model of relaxed maintenance operations which takes into account the selectively timed inspections while staying above the predefined safety threshold of each component.
Patent CA-2880038-A1 (CA)
Inventor: CABLE ALEX EZRA
IPC: A61B1/00
Filed: 2013-07-26
Abstract: An agile optical imaging system for optical coherence tomography imaging using a tunable source comprising a wavelength tunable VCL laser is disclosed. The tunable source has long coherence length and is capable of high sweep repetition rate, as well as changing the sweep trajectory, sweep speed, sweep repetition rate, sweep linearity, and emission wavelength range on the fly to support multiple modes of OCT imaging. The imaging system also offers new enhanced dynamic range imaging capability for accommodating bright reflections. Multiscale imaging capability allows measurement over orders of magnitude dimensional scales. The imaging system and methods for generating the waveforms to drive the tunable laser in flexible and agile modes of operation are also described.
Patent CA-2882410-A1 (CA)
Inventor: DILLON MICHAEL PATRICK
IPC: C07D487/04
Filed: 2013-09-17
Abstract: The present invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof; as further described herein. The present invention further provides pharmaceutical compositions comprising these compounds, and combinations comprising these compounds combined with or used with a therapeutic co-agent, as well as therapeutic uses of these compounds and compositions. These are useful in the treatment of diseases such as cancer that are associated with activation of ERKl and/or ERK2, and especially for MAPK pathway dependent cancers showing resistance to Raf and/or MEK inhibitory cancer therapeutics
Patent CA-2883268-A1 (CA)
Inventor: IMWINKELRIED THOMAS
IPC: C22C23/00
Filed: 2013-08-29
Abstract: An alloy and an implant having a three-dimensional structure based on such alloy. The alloy comprises a monophasic MgZn alloy containing from 2.0 wt. % Zn to 6 wt. % Zn, having less than 0.001 wt. % of one or more other elements with the remainder being Mg. In some embodiments, the alloy is substantially free of microgalvanic elements. In some embodiments, the alloy includes a MgZnCa alloy containing nanosized precipitates being less noble than the Mg matrix alloy and having a Zn content ranging from 3.0 wt. % Zn to 6 wt. % Zn and a calcium content ranging from 0.0005 wt. % to 1.0 wt. %, having less than 0.001 wt. % of one or more other elements with the remainder being Mg. In other embodiments, the alloy includes a MgZnCa alloy containing nanosized precipitates being less noble than the Mg matrix alloy, a plurality of nanosized precipitates being more noble than the Mg matrix and having a Zn content ranging from 3.0 wt. % Zn to 6 wt. % Zn, a calcium content ranging from 0.0005 wt. % to 1.0 wt. %, having less than 0.001 wt. % of one or more other elements with the remainder being Mg.
Patent CA-2885799-A1 (CA)
Title: Stable percarboxylic acid compositions and uses thereof
Inventor: LI JUNZHONG
IPC: C02F1/50
Filed: 2013-10-04
Abstract: The present invention relates generally to stable percarboxylic acid compositions comprising, inter alia, at least two stabilizing agents, and various uses for water treatments, including water treatments in connection with oil- and gas-field operations. The present invention also relates to slick water compositions and gel based compositions that comprise stable percarboxylic acid compositions and the use thereof in oil- and gas-field operations.
Patent CA-2888417-A1 (CA)
Inventor: ABE RIKIYA
IPC: H02J1/00
Filed: 2013-10-15
Abstract: Provided is an electric power router for constructing an electric power network system in which electric power cells are asynchronously connected to each other. The electric power router is provided with a direct-current bus, an electric power conversion leg having a function for bidirectionally converting electric power, and a control unit for controlling the operation of the electric power conversion leg. The control unit controls operation of the electric power conversion leg in either a master operating mode or a designated electric power transmission/reception operating mode. The electric power conversion leg operated in the master mode compensates for a deficit in electric power using electric power from a connected peer when the voltage of the direct-current bus is below a rated value, and sends excess electric power to a connected peer when the voltage of the direct-current bus is above the rated value. The electric power conversion leg operated in the designated electric power transmission/reception mode transmits designated electric power to a connected peer or receives designated electric power from a connected peer in accordance with a designation from a management server. The control unit places at least one electric power conversion leg in the master mode during action of the electric power router.
Patent CA-2890011-A1 (CA)
Title: Selection of platelet rich plasma components via mineral binding
Inventor: MURPHY WILLIAM L
IPC: A61F2/28
Filed: 2013-11-08
Abstract: Mineral coated devices and methods for delivering an autologous biological molecule using the mineral coated devices are disclosed. The mineral coated devices allow for the isolation and delivery of a biological molecule obtained from the same subject to avoid the safety concerns of current biological therapies obtained by recombinant methods and purification from animal sources. Methods for selectively isolating and eluting a biological molecule using the mineral coated devices are also disclosed.
Patent CA-2891486-A1 (CA)
Inventor: KOCH WALTER
IPC: A47C20/04
Filed: 2013-10-23
Abstract: An operating part (100) for a furniture control system is proposed, having a power supply (200) and at least one electrical drive unit (300, 310), wherein the operating part (100) comprises a power driver (120), a detector (140) and an operating field (160), which are integrated into a common housing (110). The operating field (160) has at last one operating element, the actuation of which is signaled to the power driver (120). The power driver (120) is designed to generate a motor voltage for the drive unit (300, 310) based on a low voltage supplied by the power supply (200) and a signaled actuation of the operating element. The detector (140) is coupled to the power driver (120) and is designed to detect a threshold position of the drive unit (300, 310) on the basis of an electrical signal transmitted by the drive unit (300, 310), and to terminate the generation of the motor voltage if a threshold position is detected.
Patent CA-2892304-A1 (CA)
Inventor: CHEUNG MUI
IPC: A61K31/553
Filed: 2013-11-22
Abstract: This invention relates to novel compounds which are inhibitors of acyl coenzyme A: diacylglycerol acyltransferase 1 (DGAT-1 ), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination with weight management therapies or other triglyceride lowering therapy for the prevention or treatment of diseases related to DGAT-1 dysfunction or where modulation of DGAT-1 activity may have therapeutic benefit.
Patent CA-2893665-A1 (CA)
Title: Mammalian cells deficient in interferon-beta production and capable of propagating porcine respiratory and reproductive syndrome virus (prrsv)
Inventor: GUELEN LARS
IPC: C12N7/02
Filed: 2013-12-20
Abstract: The present invention relates to mammalian cells capable of propagating Arterivirus, to such cells infected with Arterivirus, to cell cultures comprising such cells and to methods for the propagation of an Arterivirus in such cells.
Patent CA-2894548-A1 (CA)
Title: Anthracycline formulations
Inventor: GEYER SCOTT
IPC: A01N43/04
Filed: 2013-12-13
Abstract: The invention relates to reconstituted formulations comprising an anthracycline compound, ethanol, and water. The invention also relates to injectable compositions comprising the reconstituted formulation and Lactated Ringer's solution. Additionally, the invention relates to methods of using the formulations and compositions.
Patent CA-2896536-A1 (CA)
Inventor: PATEL VISHVAS
IPC: G06Q40/02
Filed: 2013-12-23
Abstract: The systems and methods described herein attempt to overcome the drawbacks discussed above by providing a know your customer (KYC) exchange system and method that allows for easy transmission of corporate and individual identification information to a selected financial institution. The KYC exchange system, which may be implemented by a bank, a corporation, or other party, receives as an input the laws and practicalities of a plurality of nations and regions, as well as KYC business policies of a plurality of financial institutions located across the plurality of nations and regions. Using the collected input information, the system is able to provide feedback to individuals and corporations using the exchange system regarding whether the individual or corporation has provided all of the requested and necessary identification and financial services information.
Patent CA-2898868-A1 (CA)
Inventor: KAISER ROGER
IPC: A01H3/04
Filed: 2014-01-30
Abstract: The present invention is directed to methods for improving drought stress tolerance of a cereal grain comprising applying an effective amount of at least one gibberellin to the cereal grain during early vegetative growth stage. The present invention is also directed to methods for improving yield of a cereal grain comprising applying an effective amount of at least one gibberellin to the cereal grain during early vegetative growth stage.
Patent CA-2904725-A1 (CA)
Title: Cartouche a medicament, auto-injecteur et systeme d'auto-injection
Inventor: MOUNCE R PAUL
IPC: A61M5/32
Filed: 2014-03-14
Abstract: L'invention concerne une cartouche destinée à être utilisée avec un injecteur et qui comprend un boîtier et un agencement d'identification (ID de cartouche) définissant un code qui contient des renseignements sur la cartouche qu'un injecteur peut détecter et déchiffrer. La cartouche peut également comprendre une seringue à cartouche intégrée, disposée mobile à l'intérieur du boîtier et destinée à contenir un médicament, et un agencement de verrouillage destiné à verrouiller la seringue à cartouche intégrée avec le boîtier. La cartouche peut en outre comprendre une ouverture dans le boîtier et un capuchon de cartouche destiné à retirer le protecteur d'aiguille de la seringue à cartouche intégrée. La cartouche peut présenter une structure anti-courbure pour éviter toute courbure ou flexion du capuchon de cartouche. L'injecteur peut posséder un processeur conçu pour commander les paramètres de fonctionnement de l'injecteur et un détecteur couplé en communication avec le processeur afin de détecter l'ID de la cartouche et le communiquer au microprocesseur qui déchiffre le code défini dans l'ID.
Patent CA-2907068-A1 (CA)
Title: Kir3dl1 allele classification kit and method
Inventor: HSU KATHARINE
IPC: C12Q1/68
Filed: 2014-03-13
Abstract: Disclosed herein are single nucleotide polymorphisms (SNPs) characteristic of functional subgroups of KIR3DL1. Also disclosed herein are methods for classifying KIR3DL1 alleles by using a series of oligonucleotide primers and PCR reaction conditions uniquely designed to identify group-specific SNPs from genomic DNA. The compositions and methods disclosed herein are useful in clinical settings and research laboratories, and enable prospective assessment of prognoses of various diseases and selection of most appropriate donors for HCT.
Patent CA-2912130-A1 (CA)
Title: Pyrimidin-4-yl)oxy)-1h-indole-1-carboxamide derivatives and use thereof
Inventor: GLAENZEL ULRIKE
IPC: C07D403/14
Filed: 2014-05-16
Abstract: This invention relates to certain metabolites of N-(1-methyl-5-(trifluoromethyl)-1H- pyrazol-3-yl)-5-((6-((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide In particular, the present invention relates to pharmaceutical compositions comprising these metabolites, as well as processes for their preparation and their use in the treatment of diseases.
Patent CA-2917465-A1 (CA)
Title: Miox antibody and assay
Inventor: GAUT JOSEPH P
IPC: C07K16/40
Filed: 2014-07-11
Abstract: The invention relates to compositions and methods for detecting renal injury in a subject, such as proximal tubular injury associated with acute kidney injury.
Patent CA-2917942-A1 (CA)
Title: Foam construction and mattress or pillow provided therewith
Inventor: POPPE WILLY
IPC: A47C27/14
Filed: 2014-05-27
Abstract: Foam construction (1) for use in a mattress or pillow, that comprises a base (2) extending in a longitudinal direction (L) that is made of a flexible synthetic foam, whereby this base (2) comprises two arms (4) extending in the longitudinal direction that are connected by a breathable bridge (5) that extends in the said longitudinal direction (L).
Patent CA-2918310-A1 (CA)
Inventor: LIANG YANTAO
IPC: B64C1/14
Filed: 2013-07-24
Abstract: A latch assembly (10) for a door (12) is provided. The latch assembly (10) includes a latch keep (20) carried by one of the door (12) and the surrounding structure (14) and having a strike seat (22) in which a strike (24) may be removably received, a latch (30) carried by the other of the door (12) and the surrounding structure (14) and having a catch (32) configured to engage the strike (24), and a cable (34) having a first portion (36) secured to the other of the door (12) and the surrounding structure (14) and a second portion (38) carrying the strike (24).
Patent CA-2919168-A1 (CA)
Title: Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (tag-72)
Inventor: MAGLIERY THOMAS J
IPC: A61K51/04
Filed: 2014-07-23
Abstract: Disclosed herein are methods and compositions related to single chain antibody fragments which specifically bind sialyl-Tn epitope of tumor-associated glycoprotein 72 (TAG-72).